Sign In
Buy ABT
$90.51
-0.0200 (-0.0221%)
At Close: Jun 24, 2026
5 Stocks to Buy Ahead of Q2 Earnings Next Week
07:21am, Thursday, 13'th Jul 2023
We have narrowed our search to five companies that are set to declare second-quarter earnings results next week. These are: GPC, ABT, AN, SNA, PPG.
ABT vs. LMAT: Which Stock Should Value Investors Buy Now?
01:19pm, Wednesday, 12'th Jul 2023
Investors interested in Medical - Products stocks are likely familiar with Abbott (ABT) and LeMaitre Vascular (LMAT). But which of these two stocks offers value investors a better bang for their buck
Lower Testing Demand To Weigh On Abbott's Q2?
08:00am, Wednesday, 12'th Jul 2023
Abbott will see a decline in sales given the forex headwinds and lower Covid-19-related testing demand.
Abbott (ABT) Gets FDA Approval for AVEIR DR Leadless Pacemaker
10:06am, Thursday, 06'th Jul 2023
Abbott (ABT) receives FDA approval for the AVEIR DR leadless pacemaker system, featuring the proprietary i2i technology.
Will Abbott (ABT) Beat Estimates Again in Its Next Earnings Report?
01:47pm, Wednesday, 05'th Jul 2023
Abbott (ABT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Abbott Laboratories Is A Hold Due To Its High Valuation
01:47am, Thursday, 29'th Jun 2023
I analyzed Abbott Laboratories, a healthcare company with a diversified portfolio that includes pharmaceuticals, diagnostic products, nutritional products, and medical devices. I believe Abbott has po
Abbott (ABT) EPD Sales Aid Growth Amid Currency Headwind
01:33pm, Tuesday, 27'th Jun 2023
Abbott (ABT) continues to make good progress, increasing manufacturing production and recovering market share in the Nutrition business.
Here's Why Investors Should Retain Abbott (ABT) Stock Now
01:31pm, Monday, 26'th Jun 2023
Investors are optimistic about Abbott (ABT) on continued growth in Diabetes business and upbeat guidance.
Abbott (ABT) FreeStyle Libre 2 Gets Reimbursement in France
02:09pm, Friday, 23'rd Jun 2023
Abbott's (ABT) FreeStyle Libre increased reimbursement makes it possible for more people in France with diabetes to use the recent CGM technology.
Abbott Laboratories: Offers Promising Buying Opportunity (Technical Analysis)
12:21pm, Friday, 23'rd Jun 2023
Abbott Laboratories: Offers Promising Buying Opportunity (Technical Analysis)
Abbott (ABT) Just Overtook the 50-Day Moving Average
11:09am, Friday, 23'rd Jun 2023
Abbott (ABT) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, ABT broke out above the 50-day moving average, suggesting a shor
Will Abbott Stock Rebound To Its 2022 Highs?
08:00am, Wednesday, 21'st Jun 2023
The stock has gained 10% since September 2022 compared to the S&P 500, which gained about 23% during this period.
3 Passive Income Stocks to Hold for the Next 20 Years
09:53am, Tuesday, 20'th Jun 2023
Abbott has a solid diagnostics and medical-devices portfolio and ranks as a Dividend King. Nike is a sports apparel and footwear leader that has increased its dividend for the past 15 years.
Dividend Income Update May 2023
09:00pm, Monday, 19'th Jun 2023
Without rehashing the wild ride we experienced in the market so far in 2023, I could find comfort in one thing, my dividends. Hitting the elusive four-digit mark in May has been a welcome sign for me
Abbott (ABT) EPD Sales Gain Traction, Margin Pressure Lingers
12:28pm, Monday, 12'th Jun 2023
Abbott (ABT) continues to make good progress in Nutrition, increasing manufacturing production and recovering market share in this business.
